Governance Classic Home
Laurus Labs LtdPharmaceuticalsINE947Q01028Consolidated₹1954.00+5.90 (+0.30%)Jun-26
Valuation
Market Cap₹1.06L Cr
TTM PE96.45x
Forward PE88.02x
PEG4.19
Book Value₹98.10
P/B19.92x
TTM EPS₹20.26
Fwd EPS₹22.20
TTM Revenue₹7.27K Cr
TTM PAT₹1.09K Cr
TTM EBITDA₹2.03K Cr
TTM EBIT₹1.55K Cr
Last Qtr PAT₹362.07 Cr
Last Qtr EBITDA₹638.27 Cr
Last Qtr EBIT₹514.40 Cr
Profitability
ROE20.58%
ROCE20.61%
TTM NPM15.00%
TTM EBITDA %27.98%
Curr OPM17.79%
Last OPM15.47%
Curr NPM—
Last NPM—
Curr EPS₹6.81
Last EPS₹5.17
Balance sheet
Equity₹107.97 Cr
Reserve₹5.19K Cr
Total Debt₹2,464.49 Cr
D/E0.46x
Interest %11.66%
Curr Interest₹42.22 Cr
Price / range
Close₹1954.00
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.30%
1W-0.76%
1M+7.72%
3M+42.75%
6M+98.78%
1Y+111.70%
2Y+302.97%
3Y+396.44%
5Y+200.08%
Diwali+76.02%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue1,757.16+22.6%1,580.301,509.421,566.601,432.756,089.07
Other Income20.0713.0914.3728.4521.5277.43
Total Income1,777.23+22.2%1,593.391,523.791,595.051,454.276,166.50
Interest35.2033.9131.4833.6843.89142.96
Expenditure-1,389.06-11.8%-1,334.02-1,289.35-1,306.21-1,242.83-5,172.41
PBDT000000
EBITDA499.06+52.4%375.36345.86389.66327.381,438.26
Depreciation-95.76-95.17-94.31-95.59-93.57-378.64
EBIT403.30+72.5%280.19251.55294.07233.811,059.62
PBT388.17+83.6%259.37234.44288.84211.44994.09
Tax-98.21-67.58-59.36-73.17-53.50-253.61
Equity108.05107.97107.970107.96107.97
OPM21.8416.2815.3918.4414.5416.12
Net Profit289.96+83.6%191.79175.08215.67157.94740.48
NPM16.3212.0411.4913.7710.8612.01
EPS5.37+83.3%3.553.253.992.9313.72

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue6,089.07+16.7%5,216.98+8.4%4,812.39-16.6%5,773.45+22.7%4,707.04-1.3%4,768.72
Other Income77.43100.4747.4215.9521.5527.32
Total Income6,166.50+16.0%5,317.45+9.4%4,859.81-16.1%5,789.40+22.4%4,728.59-1.4%4,796.04
Expenditure-5,172.41-7.5%-4,813.64-5.6%-4,558.34+3.8%-4,737.97-26.2%-3,753.18-6.6%-3,521.41
Interest-142.96-182.20-150.82-145.70-95.86-65.92
PBDT000000
EBITDA1,438.26+52.3%944.33+25.9%749.88-49.4%1,481.76+15.3%1,285.20-14.9%1,509.87
Depreciation-378.64-358.79-345.01-300.58-235.48-196.64
EBIT1,059.62+81.0%585.54+44.6%404.87-65.7%1,181.18+12.5%1,049.72-20.1%1,313.23
PBT994.09+97.3%503.81+67.1%301.47-71.3%1,051.43+7.8%975.41-23.5%1,274.63
Tax-253.61-123.42-77.77-291.05-225.32-318.52
Equity107.97107.850000
OPM (%)16.129.476.0018.0021.0027.00
Net Profit740.48+94.7%380.39+70.0%223.70-70.6%760.38+1.4%750.09-21.5%956.11
NPM (%)12.017.155.0013.0016.0020.00
EPS (Rs)13.72+94.3%7.06+70.1%4.15-70.7%14.14+1.2%13.97-21.7%17.85
CEPS13.707.054.1514.0913.9117.77

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue2,026.31+29.1%1,811.571,778.291,653.471,569.576,812.90
Other Income9.1811.805.7626.9610.4354.95
Total Income2,035.49+28.8%1,823.371,784.051,680.431,5806,867.85
Interest42.2240.4438.794051.50170.73
Expenditure-1,554.13-14.6%-1,462-1,457.49-1,410.70-1,355.78-5,685.97
PBDT000000
EBITDA638.27+67.0%512.11480.21403.26382.131,777.71
Depreciation-123.87-122.10-120.62-120.49-116.84-480.05
EBIT514.40+93.9%390.01359.59282.77265.291,297.66
PBT481.36+114.7%361.37326.56269.73224.221,181.88
Tax-119.37-79.46-73.45-75.98-63.14-292.03
Equity108.05107.9700107.96107.97
OPM23.6519.8218.3016.0514.1917.21
Net Profit362.07+123.9%282.09251.88194.49161.68890.14
NPM17.7915.4714.1211.5710.2312.96
EPS6.81+125.5%5.174.673.613.0216.47

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue6,812.90+22.7%5,553.96+10.2%5,040.83-16.6%6,040.55+22.4%4,935.57+2.5%4,813.51
Other Income54.9575.1026.34615.3023.66
Total Income6,867.85+22.0%5,629.06+11.1%5,067.17-16.2%6,046.55+22.1%4,950.87+2.4%4,837.17
Expenditure-5,685.97-10.5%-5,144.77-6.5%-4,830.81+2.2%-4,937.61-27.7%-3,867.02-9.4%-3,536.06
Interest-170.73-216-182.90-165.17-102.39-68.16
PBDT000000
EBITDA1,777.71+68.5%1,055.28+35.7%777.50-51.2%1,592.19+11.9%1,422.43-8.3%1,550.68
Depreciation-480.05-430.09-384.58-324.08-251.49-205.07
EBIT1,297.66+107.6%625.19+59.1%392.92-69.0%1,268.11+8.3%1,170.94-13.0%1,345.61
PBT1,181.88+144.0%484.29+104.9%236.36-78.7%1,108.94+2.3%1,083.85-16.7%1,301.11
Tax-292.03-129.88-68.15-312.30-251.42-317.29
Equity107.97107.850000
OPM (%)17.218.604.6618.3421.8926.90
Net Profit890.14+148.4%358.34+120.8%162.27-79.5%793.43-4.7%832.23-15.4%983.82
NPM (%)12.966.373.2013.1216.8120.34
EPS (Rs)16.47+147.7%6.65+123.2%2.98-79.7%14.69-4.7%15.42-16.0%18.36
CEPS16.456.642.9714.6415.3518.28

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

18
YearTypeAmountEx-Date
2027Interim Dividend1.208 May 2026
2026Interim Dividend0.831 Oct 2025
2026Interim Dividend0.809 May 2025
2025Interim Dividend0.406 Nov 2024
2025Interim Dividend0.408 May 2024
2024Interim Dividend0.402 Nov 2023
2024Interim Dividend1.210 May 2023
2023Interim Dividend0.803 Nov 2022
2023Interim Dividend1.210 May 2022
2022Interim Dividend0.817 Nov 2021
2022Interim Dividend0.811 May 2021
2021Interim Dividend0.408 Feb 2021
2021Interim Dividend0.810 Nov 2020
2020Final Dividend101 Jul 2020
2020Interim Dividend1.523 Mar 2020
2019Final Dividend1.503 Jul 2019
2018Final Dividend1.528 Jun 2018
2017Final Dividend1.506 Jul 2017

Bonus

0

No bonus history.

Split

1
YearRatioEx-Date
2020Rs.10/- to Rs.2/-29 Sep 2020
Loading company dashboard...
Fetching ratios, charts, and peers